Navigation Links
Metabolix Announces Third Quarter 2013 Financial Results
Date:11/5/2013

CAMBRIDGE, Mass., Nov. 5, 2013 /PRNewswire/ -- Metabolix, Inc. (NASDAQ: MBLX), an innovation-driven performance biomaterials company delivering sustainable solutions to the plastics, chemicals and energy industries, today reported financial results for the three months ended September 30, 2013.

"In the third quarter, we continued to make progress in the execution of our commercial strategy and in developing high value applications for our PHA products," said Richard P. Eno, President and Chief Executive Officer. 

"In biopolymers, we continue to develop markets for compostable film and bags, for performance additives and for applications requiring functional biodegradation. In October, we launched I6003rp, a new polymeric modifier for recycled PVC, and presented data on the product at a technical conference. In September, we broadened our suite of film resins with the launch of Mvera B5010, a new certified compostable resin for film and bag applications. Mvera B5010 is a product developed in collaboration with Samsung Fine Chemicals. We featured these products plus I6001, another PHA performance additive for flexible and semi-rigid PVC, at the recent K 2013 International Trade Fair held in Germany last month." 

Mr. Eno continued, "Engineering work is ongoing aimed at establishing commercial PHA manufacturing, and in parallel, we continue to advance our formulation expertise, which allows us to extend our inventory and optimize products to meet market needs."  

"In our chemicals platform, we recently achieved three key technical milestones in our program.
We demonstrated a process to efficiently recover ultra-high purity bio-GBL from fermentation broth.  We also showed that our fermentation process and P4HB technology can be adapted to produce deuterated bio-GBL. In addition, we demonstrated the robust nature of our microbial s
'/>"/>

SOURCE Metabolix
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Metabolix Announces Second Quarter 2013 Financial Results
2. Metabolix Announces Promotion of Johan van Walsem to Chief Operating Officer
3. Metabolix Executives to Present at Leading Industry Conferences
4. Discovery Labs Announces Completion of $50 Million Public Offering
5. Life Technologies Announces Third Quarter 2013 Results
6. Colby Pharmaceutical Company Announces Dramatic Results: Novel Technology Increases Influenza Vaccine Protection for Elderly Rhesus Monkeys
7. TVM Capital Group Announces Two-pronged Global Investment Strategy with Renewed MENA Focus
8. Veracyte, Inc. Announces Closing of Initial Public Offering
9. Spherix Announces Private Placement as the Company Continues to Execute its Patent Monetization Program - Spherix accepts $2.0 Million from Investors
10. Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)
11. SureClinical Announces SurePortal™, First 100% Paperless eTMF Investigator Portal for Automated Document Completion Across Mobile, Web
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... Ottawa, ON (PRWEB) April 28, 2015 ... CEO and founder, has been selected by the Ottawa ... 40 Under 40. Dr. Lem was selected from over ... and community involvement. , Prior to Spartan, Dr. Lem ... Management at DNA Genotek. He holds a Medical Degree ...
(Date:4/27/2015)... Kan. , April 27, 2015  For ... cancer cells is their ability to utilize and ... alteration of cancer cells is called the ,Warburg ... in spite of high oxygen presence, leading to ... oxygen, cancer cells still choose glucose fermentation. A ...
(Date:4/27/2015)... San Diego, Calif. (PRWEB) April 27, 2015 ... mechanisms of drug and chemical toxicity carries implications for ... featured speaker April 28 at National University , ... reception and presentation by Dr. Hanzlik, a professor at ... in drug metabolism and drug design, starts at 5 ...
(Date:4/27/2015)... , 27 avril 2015 ... spécialisée dans le développement d,une nouvelle ... les infections bactériennes polypharmacorésistantes potentiellement mortelles, ... données prouvant les promesses de son ... la lutte contre la résistance aux ...
Breaking Biology Technology:Spartan Bioscience Announces Paul Lem Named Ottawa’s Top 40 Under 40 2Study Indicates Cancer Cells Alter Glucose Metabolism to Enhance Energy Production and Cell Growth 2Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 2Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 3TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 2TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 3TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 4TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 5TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 6
... (Nasdaq: KNSY ) today announced that it ... SPNC ) that they reached a cumulative $20 million ... from Kensey Nash in May 2008. Accordingly, this triggered ... Nash.  As previously disclosed, the Company expects to record ...
... 2011  Stemline Therapeutics, Inc. today announced that Ivan Bergstein, ... present at the Oppenheimer 22nd Annual Healthcare Conference on ... the Waldorf Astoria Hotel in New York City. ... Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company ...
... Insurance Company, a Medicare Part D provider, with offices ... arbitration between the company and ProCare, its former pharmacy ... suit against ProCare based on Fox,s allegations of negligence ... Barotz, chairman of Fox Insurance Company commented: "Fox Insurance ...
Cached Biology Technology:Stemline Therapeutics, Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference 2Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager 2
(Date:4/2/2015)... , April 2, 2015 According ... 2015 attributed to somewhat higher than 125 MSEK. This ... year-end report 2014 that revenues for Q1 2015 would ... company reported for Q4 2014. The operating result for ... negative. The complete interim report will as previously communicated ...
(Date:4/1/2015)... , Apr. 1, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... Wocket smart wallets is underway to early access pre-order ... group includes usage at retail outlets including Walmart, Target, ... Users report Wocket was accepted at all outlets and ...
(Date:3/31/2015)... YORK , March 31, 2015  Elephant Talk ... "Company"), a global provider of Software Defined Network Architecture ... today announced total revenue of approximately $20.4 million for ... a restated $19.5 million for the year ended December ... calendar 2014, the Company had completed its multi-year transition ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... The plant hormone indole-3-acetic acid (IAA), commonly referred to ... growth and development. Auxin influences development by affecting the ... cell division and cell expansion in specific plant tissues ... e.g. for leaves, roots, and floral organs to develop ...
... or Sultans of Soil, they're just clever Lab guys. A ... this week's Science Magazine with a new way to count ... world beneath our feet. , "Computational Improvements Reveal Great Bacterial ... Murray Wolinsky and John Dunbar, of Los Alamos' Bioscience Division, ...
... In 1909, while harvesting a typical corn crop (Zea mays) ... that it was initially believed to be a new species. ... and the specimen was designated Zea ramosa (from the Latin ... single gene, later named ramosa1, both the ear and the ...
Cached Biology News:Scientists find microRNAs regulate plant development 2Scientists find microRNAs regulate plant development 3Scientists find microRNAs regulate plant development 4Comparison of Cocaine, Methamphetamine ‘Highs?Finds Differences 2$6.5 Million Grant for Microarray Center at Yale School of Medicine 2
... Signet Level 2 Detection System combines ... chemical bonding principle and Signets unique ... sensitivity, specificity and reliablility. Signet reagents ... both manual and automated protocols. ,Signets ...
... Signet Level 2 Detection System combines ... chemical bonding principle and Signets unique ... sensitivity, specificity and reliablility. Signet reagents ... both manual and automated protocols. ...
6X DNA Gel Loading Buffer is intended for gel electrophoresis of DNA fragments or PCR products....
Xanthine Oxidase (Bovine Buttermilk). Monospecific by IEP. Some cross reactivity with Xanthine Oxidase of other species and tissues may occur....
Biology Products: